<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Approaches and Clinical Perspectives of Anthocyanins in the Management of" exact="Viral" post="Diseases Mohammadi PourPardis1FakhriSajad2AsgarySedigheh3FarzaeiMohammad Hosein2*EcheverríaJavier4*[], 1Department of Pharmacognosy, School of"/>
 <result pre="and Clinical Perspectives of Anthocyanins in the Management of Viral" exact="Diseases" post="Mohammadi PourPardis1FakhriSajad2AsgarySedigheh3FarzaeiMohammad Hosein2*EcheverríaJavier4*[], 1Department of Pharmacognosy, School of Pharmacy"/>
 <result pre="the need to identify novel, effective, and safe alternatives against" exact="viral" post="diseases. Nature has been of the most exceptional help"/>
 <result pre="developing novel multi-target antiviral compounds, affecting several steps of the" exact="viral" post="life cycle and host proteins. For that matter and"/>
 <result pre="virus life cycle, treatment strategies, and therapeutic targets of several" exact="viral" post="diseases with a particular focus on anthocyanins as promising"/>
 <result pre="drug delivery systems are also considered. anthocyanins natural compounds antiviral" exact="viral" post="diseases signaling pathways therapeutic targets fig-count: table-count: equation-count: ref-count:"/>
 <result pre="their ability to borrow molecular equipment from host cells to" exact="complete" post="their replication cycle, viruses have a few targets for"/>
 <result pre="Telenti, 1998; Revuelta-Herrero et al., 2018). The catastrophic rise in" exact="viral" post="infections and related mortality urged a growing need to"/>
 <result pre="1998; Revuelta-Herrero et al., 2018). The catastrophic rise in viral" exact="infections" post="and related mortality urged a growing need to provide"/>
 <result pre="growing need to provide safe and effective drugs to treat" exact="viral" post="diseases. It has yet remained a challenge due to"/>
 <result pre="small number of targets in viruses, the rapid evolution of" exact="viral" post="genes, the rapid emergence of drug-resistant pathways, and the"/>
 <result pre="rapid emergence of drug-resistant pathways, and the appearance of new" exact="viral" post="strains through mutations (Martins et al., 2016). Furthermore, considering"/>
 <result pre="(Martins et al., 2016). Furthermore, considering the increasing threat of" exact="viral" post="diseases, the emphasis is always on the need to"/>
 <result pre="to identify suitable alternative therapies targeting different steps in the" exact="viral" post="replication cycle (Perrin and Telenti, 1998; Gogineni et al.,"/>
 <result pre="compounds already with proven antiviral value in preventing and/or attenuating" exact="viral" post="diseases or that are waiting to be evaluated for"/>
 <result pre="to improve the anthocyanin delivery system. Current Therapeutic Approaches for" exact="Viral" post="Diseases and Their Restrictions Antiviral drugs can be categorized"/>
 <result pre="improve the anthocyanin delivery system. Current Therapeutic Approaches for Viral" exact="Diseases" post="and Their Restrictions Antiviral drugs can be categorized into"/>
 <result pre="cell membrane or receptor(s) is the first phase of the" exact="viral" post="life cycle called fusion/entry. Fusion/entry inhibitors have been more"/>
 <result pre="called fusion/entry. Fusion/entry inhibitors have been more provided for human" exact="immunodeficiency" post="virus (HIV) treatment (Soriano et al., 2009; Tilton and"/>
 <result pre="2009; Tilton and Doms, 2010; Fumakia et al., 2016) and" exact="respiratory" post="syncytial virus (RSV) prevention (Hu and Robinson, 2010; Lanari"/>
 <result pre="phase, are also of the most attractive candidates to inhibit" exact="viral" post="entry/fusion. A novel lipopeptide known as myrcludex B also"/>
 <result pre="co-transporting polypeptide (NTCP); the co-receptor which is crucial for either" exact="hepatitis" post="B virus (HBV) and hepatitis D virus (HDV) entry"/>
 <result pre="which is crucial for either hepatitis B virus (HBV) and" exact="hepatitis" post="D virus (HDV) entry into hepatocytes (Uhl et al.,"/>
 <result pre="activates M2 proton channels following virus entry to acidify the" exact="viral" post="interior and weaken the electrostatic interaction to allow viral"/>
 <result pre="the viral interior and weaken the electrostatic interaction to allow" exact="viral" post="uncoating (Pinto et al., 1992). Uncoating inhibitors have been"/>
 <result pre="uncoating, nucleic acid synthesis is the third step of the" exact="viral" post="life cycle, which is mediated by viral enzymes, including"/>
 <result pre="step of the viral life cycle, which is mediated by" exact="viral" post="enzymes, including RNA polymerase, DNA polymerase, and reverse transcriptase."/>
 <result pre="these enzymes have been considered as alternative targets in many" exact="viral" post="infections such as HBV (De Clercq, 2015), herpes simplex"/>
 <result pre="enzymes have been considered as alternative targets in many viral" exact="infections" post="such as HBV (De Clercq, 2015), herpes simplex virus-1/2"/>
 <result pre="in many viral infections such as HBV (De Clercq, 2015)," exact="herpes" post="simplex virus-1/2 (HSV-1/2) and HIV-1. There are more targets"/>
 <result pre="also, more drugs against HIV in comparison to other viruses." exact="Viral" post="polymerase inhibitors are classified into nucleotide reverse transcriptase inhibitors"/>
 <result pre="al., 2010). Altogether, most antiretroviral therapies did not eradicate the" exact="viral infection." post="Instead, they limited the immune recovery and their long-term"/>
 <result pre="antiretroviral therapies did not eradicate the viral infection. Instead, they" exact="limited" post="the immune recovery and their long-term use results in"/>
 <result pre="target integration have also been approved for the treatment of" exact="HIV infection." post="Since integrase is a necessary enzyme for the replication"/>
 <result pre="step involving the integration of host cell DNA to the" exact="viral" post="genome, it has become a validated target for developing"/>
 <result pre="al., 1999b; Pommier et al., 2005; Grinsztejn et al., 2007)." exact="Viral" post="proteases also signify an appropriate target for the development"/>
 <result pre="for the development of novel antiviral agents against HIV and" exact="hepatitis" post="C virus (HCV) infections (Eron Jr, 2000). Furthermore, the"/>
 <result pre="novel antiviral agents against HIV and hepatitis C virus (HCV)" exact="infections" post="(Eron Jr, 2000). Furthermore, the genome of HCV owns"/>
 <result pre="from the host cell is the final step of the" exact="virus infection" post="cycle. Some drugs inhibit this phase through acting on"/>
 <result pre="the host cell is the final step of the virus" exact="infection" post="cycle. Some drugs inhibit this phase through acting on"/>
 <result pre="cycle. Some drugs inhibit this phase through acting on the" exact="viral" post="protein involved in such a process, which have been"/>
 <result pre="process, which have been approved for the treatment of InfV" exact="infection" post="(Hayden et al., 1997; Gubareva et al., 2000). The"/>
 <result pre="Clercq, 2006). Most of the antiviral agents not only inhibit" exact="viral" post="replication but also alter cellular metabolism, which creates the"/>
 <result pre="there is no suitable vaccine or therapeutic option for many" exact="viral" post="infections. Conventional antiviral drugs are limited by the inadequate"/>
 <result pre="therapeutic option for many viral infections. Conventional antiviral drugs are" exact="limited" post="by the inadequate response, the rapid development of resistance,"/>
 <result pre="antiviral efficacy, consequent resistant variants, and the toxicity incidence. Drug" exact="hypersensitivity" post="reactions, which vary in clinical manifestations, severity, and frequency,"/>
 <result pre="development of innovative and novel therapeutic and preventive strategies for" exact="viral" post="infections is of particular importance. Further research is necessary"/>
 <result pre="of innovative and novel therapeutic and preventive strategies for viral" exact="infections" post="is of particular importance. Further research is necessary to"/>
 <result pre="Figure 1 Targeting host proteins and several steps of the" exact="viral" post="life cycle by current therapeutic and alternative natural products"/>
 <result pre="current therapeutic and alternative natural products (in red). HIV, human" exact="immunodeficiency" post="viruses; RSV, respiratory syncytial virus; HBV, hepatitis B virus;"/>
 <result pre="alternative natural products (in red). HIV, human immunodeficiency viruses; RSV," exact="respiratory" post="syncytial virus; HBV, hepatitis B virus; HSV-1/2, herpes simplex"/>
 <result pre="red). HIV, human immunodeficiency viruses; RSV, respiratory syncytial virus; HBV," exact="hepatitis" post="B virus; HSV-1/2, herpes simplex virus-1/2, NtRTIs, nucleotide reverse"/>
 <result pre="viruses; RSV, respiratory syncytial virus; HBV, hepatitis B virus; HSV-1/2," exact="herpes" post="simplex virus-1/2, NtRTIs, nucleotide reverse transcriptase inhibitors; NRTIs, nucleoside"/>
 <result pre="PGC-1α, peroxisome proliferator-activated receptor gamma coactivator 1-alpha. New Targets to" exact="Combat" post="Viral Infections: Host Proteins, Nucleic Acids, and Antibodies In"/>
 <result pre="peroxisome proliferator-activated receptor gamma coactivator 1-alpha. New Targets to Combat" exact="Viral" post="Infections: Host Proteins, Nucleic Acids, and Antibodies In addition"/>
 <result pre="Proteins, Nucleic Acids, and Antibodies In addition to previously described" exact="viral" post="targets, new classes of antiviral drugs targeting host factors"/>
 <result pre="proteins participating in the replication of viruses positively modulate the" exact="viral infection," post="and their inhibition has recently shown new insights into"/>
 <result pre="recent advances in clinical studies indicated additional targets to combat" exact="viral infection." post="Targeting the host cell factors involved in the HIV-1"/>
 <result pre="HIV-1 to antiviral drugs (Opar, 2007). While drugs directed to" exact="viral" post="proteins act against specific viral infections, those targeting host"/>
 <result pre="2007). While drugs directed to viral proteins act against specific" exact="viral" post="infections, those targeting host proteins have a wide range"/>
 <result pre="been considered as another approach making cells virtually resistant to" exact="HIV infection" post="through knockout of CXCR4 or CCR5 receptors (Holt et"/>
 <result pre="considered as another approach making cells virtually resistant to HIV" exact="infection" post="through knockout of CXCR4 or CCR5 receptors (Holt et"/>
 <result pre="growth factor, also strongly inhibited the replication of poxviruses and" exact="vaccinia" post="virus, respectively (Yang et al., 2005). The current studies"/>
 <result pre="Inhibitors of IL8 and targeting IL12, IL2, interferon-gamma (IFNγ) and" exact="tumor" post="necrosis factor-α (TNF-α) are other possible immune-modulators used to"/>
 <result pre="factor-α (TNF-α) are other possible immune-modulators used to combat some" exact="viral" post="infections (Koumbi, 2015). It is now well known that"/>
 <result pre="(TNF-α) are other possible immune-modulators used to combat some viral" exact="infections" post="(Koumbi, 2015). It is now well known that several"/>
 <result pre="al., 2014). Therapeutic antibodies have also shown promising effects against" exact="viral" post="infections, including RSV, HIV, avian InfV, and rabies viruses"/>
 <result pre="effects against viral infections, including RSV, HIV, avian InfV, and" exact="rabies" post="viruses (Chen and Dimitrov, 2012). Nowadays, ribozymes, aptamers, and"/>
 <result pre="target HIV, HCV, HBV, Marburg virus, Ebola virus and influenza" exact="viral" post="genes (Zeller and Kumar, 2011). Besides, several other classes"/>
 <result pre="of a clinical trial, by influencing the synthesis of the" exact="viral" post="terminase complex (Kropeit et al., 2017). It did not"/>
 <result pre="cidofovir, foscarnet, and ganciclovir-resistance viruses (Melendez and Razonable, 2015). The" exact="primary" post="inhibitors of terminase, benzimidazole derivatives (Valiente‐Echeverría et al., 2015),"/>
 <result pre="inhibited the replication of CMV at the final steps of" exact="viral" post="DNA synthesis (Champier et al., 2008). The other new"/>
 <result pre="DDX3 is a part of the innate immunity response against" exact="viral" post="infections. It is interesting to note that some RNA"/>
 <result pre="and targeting helicase could be a novel strategy to combat" exact="viral" post="diseases. One of the other new classes of antiviral"/>
 <result pre="classes of antiviral drugs with the potential to treat HSV" exact="infections" post="is the helicase-primase inhibitors (Kleymann et al., 2002), through"/>
 <result pre="and amino acids (Han et al., 1998). The number of" exact="secondary" post="metabolites showed a unique antiviral mechanism of action and"/>
 <result pre="Role of Natural Products for the Prevention and Treatment of" exact="Viral" post="Diseases For years, natural medicines have been used for"/>
 <result pre="of Natural Products for the Prevention and Treatment of Viral" exact="Diseases" post="For years, natural medicines have been used for the"/>
 <result pre="have been used for the treatment and prophylactic of several" exact="viral" post="infections (Koehn and Carter, 2005; Kitazato et al., 2007;"/>
 <result pre="been used for the treatment and prophylactic of several viral" exact="infections" post="(Koehn and Carter, 2005; Kitazato et al., 2007; Newman"/>
 <result pre="multi-target agents of high biochemical specificity and chemical diversity with" exact="lower" post="cost and more covering mechanisms. They all help to"/>
 <result pre="use of several natural plant-derived products for the treatment of" exact="HIV infection." post="It has been previously shown that terpenoids, coumarins and"/>
 <result pre="possess promising activities for the prevention and attenuation of the" exact="HIV infection." post="Flavonoids have been found to inhibit fusion (Li et"/>
 <result pre="The Sophora alkaloids also showed the antiviral potential to inhibit" exact="liver fibrosis," post="reduce the destruction of liver cells, inhibit viral replication,"/>
 <result pre="the antiviral potential to inhibit liver fibrosis, reduce the destruction" exact="of liver" post="cells, inhibit viral replication, and promote the bile flow"/>
 <result pre="inhibit liver fibrosis, reduce the destruction of liver cells, inhibit" exact="viral" post="replication, and promote the bile flow (Liu et al.,"/>
 <result pre="to HSV-1 (Chang et al., 2004). These hydrolyzable tannins inhibited" exact="viral" post="entry phase, including attachment and penetration, thereby showing anti-RSV"/>
 <result pre="and B (Figure 2) (Smeriglio et al., 2016). Figure 2" exact="General" post="anthocyanin’s structure. Glycosidic bonds are formed at 3 or"/>
 <result pre="in stability and color. The fundamental differences would be the" exact="total" post="number and position of OH groups, nature, number, and"/>
 <result pre="Pojer et al., 2013). Anthocyanin-rich formula inhibited H2O2- and TNF-α-induced" exact="vascular" post="endothelial growth factor release (Bagchi et al., 2004), and"/>
 <result pre="exerting its anti-angiogenic and anticarcinogenic activities. Anthocyanins also improved the" exact="visual" post="function through the inhibition of transitory myopia, improving the"/>
 <result pre="of retin, enhancing dark adaptation, and decreasing eye fatigue in" exact="glaucoma" post="disease (Tsuda, 2012). From the neuroprotective point of view,"/>
 <result pre="retin, enhancing dark adaptation, and decreasing eye fatigue in glaucoma" exact="disease" post="(Tsuda, 2012). From the neuroprotective point of view, anthocyanins"/>
 <result pre="2013) HSV-1 Delphinidin-3-rutinoside Solanum melongena Inhibite the HSV-1 replication, reduce" exact="viral" post="proteins expression, and reduce NOX4 expression (Di Sotto et"/>
 <result pre="and reduce NOX4 expression (Di Sotto et al., 2018) HSV-1" exact="Total" post="anthocyanins Fragaria x ananassa Increase the anthocyanins content and"/>
 <result pre="substance Vigna angularis Effect on the early phase of the" exact="infection" post="cycle (Kawai and Fujita, 2007) InfV A and CV-B1"/>
 <result pre="infection cycle (Kawai and Fujita, 2007) InfV A and CV-B1" exact="Total" post="anthocyanins Fragaria vesca, Rubus idaeus, Vaccinium myrtillis, and V."/>
 <result pre="and intervene with the ROS-mediated cell damage caused by InfV" exact="Infection" post="(Kim and Chung, 2018) Adenovirus 36 Kuromanin chloride and"/>
 <result pre="Infection (Kim and Chung, 2018) Adenovirus 36 Kuromanin chloride and" exact="total" post="extract Morus alba Inhibits viral replication (Na et al.,"/>
 <result pre="Adenovirus 36 Kuromanin chloride and total extract Morus alba Inhibits" exact="viral" post="replication (Na et al., 2014) BT2, T4 and simian"/>
 <result pre="(Na et al., 2014) BT2, T4 and simian rotavirus SA-11" exact="Total" post="anthocyanins Vaccinium macrocarpon Inhibited the viral adsorption of phage"/>
 <result pre="and simian rotavirus SA-11 Total anthocyanins Vaccinium macrocarpon Inhibited the" exact="viral" post="adsorption of phage T4 and the replication of rotavirus"/>
 <result pre="of rotavirus (Lipson et al., 2007) HAV, FCV-F9 and MNV-1" exact="Total" post="anthocyanins Vitis vinifera Inhibite the viral adsorption and have"/>
 <result pre="HAV, FCV-F9 and MNV-1 Total anthocyanins Vitis vinifera Inhibite the" exact="viral" post="adsorption and have less effect on replication (Joshi et"/>
 <result pre="prepare more potent protection (Niemenak et al., 2006) InfV A" exact="Total" post="anthocyanins Lycium barbarum Attenuate the inflammatory cytokines in the"/>
 <result pre="IL-2 (Ren et al., 2012) InfV subtypes A/Vama/5/003 and A/Vama/3/003." exact="Total" post="anthocyanins Aronia melanocarpa Inhibit the reproduction of InfV in"/>
 <result pre="initial phase (Valcheva-Kuzmanova et al., 2003) Adenovirus and HIV-1 IIIB" exact="Total" post="anthocyanins Punica granatum Bind irreversibly or strongly to the"/>
 <result pre="on gp120 (Neurath et al., 2004) HSV-1, HSV-2, and ACVres" exact="Total" post="anthocyanins Lamiaceae family Inhibit the virus adsorption stage and"/>
 <result pre="the InfV A and B. The second fraction anthocyanins prevented" exact="viral" post="attachment and entry to cells, as well as their"/>
 <result pre="effect of S. paniculatum against murine encephalomyocarditis virus (EMCv), human" exact="herpes" post="virus type 1 (HHV-1), and vaccinia virus strains Western"/>
 <result pre="S. paniculatum against murine encephalomyocarditis virus (EMCv), human herpes virus" exact="type 1" post="(HHV-1), and vaccinia virus strains Western Reserve (VACV-WR). According"/>
 <result pre="encephalomyocarditis virus (EMCv), human herpes virus type 1 (HHV-1), and" exact="vaccinia" post="virus strains Western Reserve (VACV-WR). According to the results,"/>
 <result pre="a target for therapeutic development of new antiviral compounds for" exact="acute" post="and chronic HCV, where NS3- mediated processing of the"/>
 <result pre="for therapeutic development of new antiviral compounds for acute and" exact="chronic" post="HCV, where NS3- mediated processing of the polyprotein is"/>
 <result pre="antiviral activity of strawberry fruit juice against coxsackievirus B5, poliovirus" exact="type 1" post="and echovirus 7 (Konowalchuk and Speirs, 1976). Carvalho et"/>
 <result pre="Carvalho et al. studied five strawberry cultivars and quantified their" exact="total" post="anthocyanins content (TA). The extracts were evaluated for in"/>
 <result pre="two first cultivars also showed the most activity against the" exact="herpes" post="virus, while the camino real cultivar had the lowest"/>
 <result pre="aqueous extract, respectively, indicated potent and little antiviral activities against" exact="rabies" post="virus (RV). According to the findings, the anthocyanins fractions"/>
 <result pre="extract affect preliminary adsorption phase and the preliminary phase of" exact="viral" post="replication. The antiviral activity of V. angularis was not"/>
 <result pre="were evaluated on Picornaviridae [e.g., coxsackievirus B1 (CV-B1) and poliovirus" exact="type 1" post="(PV-1)], Paramyxoviridae (e.g. human respiratory syncytial virus A2 (HRSV-A2)),"/>
 <result pre="B1 (CV-B1) and poliovirus type 1 (PV-1)], Paramyxoviridae (e.g. human" exact="respiratory" post="syncytial virus A2 (HRSV-A2)), and Orthomyxoviridae such as InfV"/>
 <result pre="berries inhibited the replication of InfV A and CV-B1. The" exact="total" post="extract of strawberry and bilberry inhibited the highest degree"/>
 <result pre="was perceived between the antiviral activity of berry extracts and" exact="total" post="polyphenol content (Sekizawa et al., 2013). Searches demonstrated that"/>
 <result pre="results, wildberry is an auspicious source of anthocyanins to combat" exact="viral" post="infections. Rubus coreanus Miq. The outcomes of HPLC-PDA-MS/MS analysis"/>
 <result pre="reported the antiviral activity of RCS fraction (RCS-F1) and the" exact="total" post="extract against food-borne viral feline calicivirus-F9 (FCV-F9), murine norovirus-1"/>
 <result pre="of RCS fraction (RCS-F1) and the total extract against food-borne" exact="viral" post="feline calicivirus-F9 (FCV-F9), murine norovirus-1 (MNV-1), and surrogates (FBVS)."/>
 <result pre="infected cells with FCV-F9 or MNV-1, which resulted in a" exact="complete" post="inhibition. The results showed that the RCS-F1 disrupted viral"/>
 <result pre="a complete inhibition. The results showed that the RCS-F1 disrupted" exact="viral" post="capsids and their expansion, and impaired the attachment to"/>
 <result pre="through binding to RNA polymerase of MNV-1 and expansion of" exact="viral" post="capsids (Lee et al., 2016a). In BALB/c mice, black"/>
 <result pre="al., 2016a). In BALB/c mice, black raspberry also reduced the" exact="viral" post="titers of Inflv A and B in the lungs"/>
 <result pre="RCS binds to hemagglutinin protein, significantly inhibits hemagglutination and disrupts" exact="viral" post="particles (Lee et al., 2016b). In general, such research"/>
 <result pre="derivatives with potential use in the prevention and treatment of" exact="viral" post="disease. Morus alba L. Cyanidin hexoside, cyanidin rhamnosylhexoside, cyanidin"/>
 <result pre="belongs to the Moraceae family, with antiviral activity to combat" exact="hepatitis" post="B and C viruses (Jacob et al., 2007). Kim"/>
 <result pre="research, MAS and MAJ also showed antiviral effects against foodborne" exact="viral" post="surrogates (Lee et al., 2014). Nam et al. studied"/>
 <result pre="control group. Moreover, the ME reduced the pro-inflammatory cytokines, like" exact="monocyte" post="chemoattractant protein‐1 (MCP-1) and TNF-α, and also decreased the"/>
 <result pre="and TNF-α, and also decreased the concentration of macrophages and" exact="infiltrating" post="immune cells in the fat layers of epiderm. Therefore,"/>
 <result pre="the dietary ME might lead to prevention or treatment of" exact="obesity" post="and inflammation caused by Ad36 (Na et al., 2014)."/>
 <result pre="that MAJ might be useful in the prevention of foodborne" exact="viral infection," post="treatment of obesity and inflammation caused by Ad36 and"/>
 <result pre="useful in the prevention of foodborne viral infection, treatment of" exact="obesity" post="and inflammation caused by Ad36 and may have a"/>
 <result pre="have a prosperous future in the prevention and treatment of" exact="viral" post="disease. Vaccinium macrocarpon Aiton Several studies revealed the antiviral"/>
 <result pre="assessed the antiviral effects of cranberry juice (CJ) on unconnected" exact="viral" post="species. The treatment of bacteriophage T2 (BT2) with CJ"/>
 <result pre="treatment of bacteriophage T2 (BT2) with CJ showed no detectable" exact="virus infection." post="Like BT2, almost identical data were reported for the"/>
 <result pre="an antiviral agent, CJ suggested being considered as an effective" exact="viral" post="system to that of a mammalian enteric virus. The"/>
 <result pre="therapeutic potential and may be a suitable natural extract for" exact="viral" post="diseases. Vitis vinifera L. Delphinidin, cyanidin, petunidin, peonidin, malvidin,"/>
 <result pre="against three viruses: feline calicivirus (FCV-F9), murine norovirus (MNV-1), and" exact="hepatitis" post="A virus (HAV). They also studied the activity of"/>
 <result pre="with time. The GSE possessed some mild activities at the" exact="viral" post="adsorption stage of viruses with minor activity on the"/>
 <result pre="the replication stage. GSE also showed positive effects on foodborne" exact="viral" post="diseases (Joshi et al., 2015). Previously, GSE was evaluated"/>
 <result pre="replication phases of MNV-1, FCV-F9, and HAV prior to a" exact="viral infection" post="was evaluated for GSE, which resulted in the decrement"/>
 <result pre="phases of MNV-1, FCV-F9, and HAV prior to a viral" exact="infection" post="was evaluated for GSE, which resulted in the decrement"/>
 <result pre="antiviral effects by producing Th1-derived cytokine interferon- γ (IFN-γ) through" exact="peripheral" post="mononuclear cells, proposing that the effective immunostimulatory activity of"/>
 <result pre="broad-spectrum effects of GSE showed potential for use in the" exact="viral" post="infections and also food quality and safety. Theobroma cacao"/>
 <result pre="effects of GSE showed potential for use in the viral" exact="infections" post="and also food quality and safety. Theobroma cacao L."/>
 <result pre="immune system responses and procured more potent protection against InfV" exact="disease" post="(Kamei et al., 2016). In another study, the anti-HIV"/>
 <result pre="T. cacao is a promising plant containing anthocyanins to tackle" exact="viral" post="infections. Lycium barbarum L. The anthocyanin content of Lycium"/>
 <result pre="lacto-wolfberry (LWB) supplementation reduced the pathology and symptoms of InfV" exact="infection" post="through attenuation of inflammatory cytokines, such as TNFα and"/>
 <result pre="the same diet. However, it raised IL-2 through increasing the" exact="systemic" post="lymphocyte T (Ren et al., 2012). In this regard,"/>
 <result pre="immunomodulating properties of wolfberry may increase the host’s defense against" exact="viral infection;" post="though, the scientific mark is lacking. Aronia melanocarpa (Michx.)"/>
 <result pre="the virion and anthocyanins influenced the adsorption stage of InfV" exact="infection" post="(Valcheva-Kuzmanova et al., 2003). In another study, the anti-infV"/>
 <result pre="head in a non-specific circumstance. It is also inhibiting the" exact="viral" post="proteins, which are impressing the maturation by blocking cellular"/>
 <result pre="blocking cellular signaling pathway (Park et al., 2013). So, in" exact="viral" post="infections, promising effects might be expected from AMFJ through"/>
 <result pre="against HSV. The inhibitory activities of phenolic compounds against HSV" exact="type 1" post="(HSV-1), type 2 (HSV-2), and HSV-1 acyclovir-resistant strain (ACVres)"/>
 <result pre="inhibitory activities of phenolic compounds against HSV type 1 (HSV-1)," exact="type 2" post="(HSV-2), and HSV-1 acyclovir-resistant strain (ACVres) were assayed in"/>
 <result pre="chance to use the Lamiaceae family for therapeutic application against" exact="viral" post="diseases like HSV. Purified Antiviral Anthocyanin The antiviral findings"/>
 <result pre="isolated from rich-anthocyanin plants may have an effective role against" exact="viral" post="infections (Jassim and Naji, 2003). Swaminathan et al. reported"/>
 <result pre="from rich-anthocyanin plants may have an effective role against viral" exact="infections" post="(Jassim and Naji, 2003). Swaminathan et al. reported the"/>
 <result pre="studied the effect of anthocyanin, delphinidin, and cyanidin on the" exact="viral" post="infections of flaviviruses family, including west nile virus (WNV),"/>
 <result pre="the effect of anthocyanin, delphinidin, and cyanidin on the viral" exact="infections" post="of flaviviruses family, including west nile virus (WNV), dengue"/>
 <result pre="interfered with the attachment, adsorption, and entrance stages of the" exact="viral" post="cycle and has a direct effect on the virus"/>
 <result pre="reported with acidic pH variation in the endosomal system for" exact="viral" post="fusion. It was also shown that anthocyanins exhibiting antiviral"/>
 <result pre="by a virucidal activity instead of an inhibitory activity of" exact="viral" post="fusion that was dependent on pH. Delphinidin also decreased"/>
 <result pre="fusion that was dependent on pH. Delphinidin also decreased the" exact="viral" post="activity of DENV and ZIKV. Finally, delphinidin was reported"/>
 <result pre="DENV and ZIKV. Finally, delphinidin was reported to disrupt the" exact="viral" post="activity of three viruses of the flaviviruses family in"/>
 <result pre="according to the importance of purified antiviral anthocyanin in combating" exact="viral" post="diseases, clarifying the exact pharmacological mechanisms of action could"/>
 <result pre="of action could pave the road for the treatment of" exact="viral" post="infections. Therapeutic and Clinical Antiviral Application of Anthocyanins In"/>
 <result pre="elderberry (Sambucus nigra L.), has been used in treating the" exact="viral" post="disease like colds and flu from past to present"/>
 <result pre="(Sambucus nigra L.), has been used in treating the viral" exact="disease" post="like colds and flu from past to present (Roxas"/>
 <result pre="proper effect of elderberry extract against InfV A and B" exact="infection" post="(Kong, 2009). In a randomized, double-blind, placebo-controlled study, elderberry"/>
 <result pre="plants containing anthocyanins on the number, duration, and symptoms of" exact="viral" post="disease, especially common cold and flu (the studies are"/>
 <result pre="effects of some plant containing anthocyanins in the treatments of" exact="viral" post="infections. Study Treatment Dosage Results (Kong, 2009) InfV 175"/>
 <result pre="Improvement of the symptoms, including fever, within 2 days. A" exact="complete" post="cure was achieved within 2 to 3 days. (Schütz"/>
 <result pre="ordinarily consumed in the guise of a meal, there is" exact="limited" post="information about their bioavailability and pharmacokinetic. To comprehend the"/>
 <result pre="and then the bioavailability of anthocyanins. Some studies showed that" exact="consumption" post="of anthocyanin with foods influences the absorption and excretion"/>
 <result pre="are easily oxidized into quinones. Moreover, they are precipitated by" exact="external" post="factors like temperature or pH, which all affect their"/>
 <result pre="antiviral properties (Amin et al., 2017; Ahsan et al., 2018)." exact="Protein" post="encapsulation of procyanidins could attenuate their degradation under ultraviolet"/>
 <result pre="medicine has always been considered as an excellent source against" exact="viral" post="infections, and their discoveries would help to improve derivatives"/>
 <result pre="to improve derivatives and lead-compounds to treat or even cure" exact="viral" post="diseases. The development of novel plant-derived antiviral agents is"/>
 <result pre="plant-derived antiviral agents is among the top global priorities as" exact="viral" post="infections have high mortality rates and are not yet"/>
 <result pre="antiviral agents is among the top global priorities as viral" exact="infections" post="have high mortality rates and are not yet curable."/>
 <result pre="show its antiviral effects through binding to host cells, inhibiting" exact="viral" post="life cycle, or stimulating host immunity, strengthens the idea"/>
 <result pre="capable of enhancing immunity and reducing the cost, toxicity, and" exact="viral" post="resistance, as well as finding their virus-specific targets and"/>
 <result pre="these lead-compounds to find even more efficient drugs against several" exact="viral" post="infections. Drug delivery must also be improved by new"/>
 <result pre="The authors declare that the research was conducted in the" exact="absence of" post="any commercial or financial relationships that could be construed"/>
 <result pre="construed as a potential conflict of interest. Abbreviations HIV, human" exact="immunodeficiency" post="virus; RSV, respiratory syncytial virus; NTCP, Na+/taurocholate co-transporting polypeptide;"/>
 <result pre="potential conflict of interest. Abbreviations HIV, human immunodeficiency virus; RSV," exact="respiratory" post="syncytial virus; NTCP, Na+/taurocholate co-transporting polypeptide; HBV, hepatitis B"/>
 <result pre="virus; RSV, respiratory syncytial virus; NTCP, Na+/taurocholate co-transporting polypeptide; HBV," exact="hepatitis" post="B virus; HCV, hepatitis C virus; HDV, hepatitis D"/>
 <result pre="virus; NTCP, Na+/taurocholate co-transporting polypeptide; HBV, hepatitis B virus; HCV," exact="hepatitis" post="C virus; HDV, hepatitis D virus; InfV, Influenza virus;"/>
 <result pre="polypeptide; HBV, hepatitis B virus; HCV, hepatitis C virus; HDV," exact="hepatitis" post="D virus; InfV, Influenza virus; HSV-1/2, herpes simplex virus-1/2;"/>
 <result pre="C virus; HDV, hepatitis D virus; InfV, Influenza virus; HSV-1/2," exact="herpes" post="simplex virus-1/2; NtRTIs, nucleotide reverse transcriptase inhibitors; NRTIs, nucleoside"/>
 <result pre="proliferator-activated receptor gamma coactivator 1-alpha, EMCv, encephalomyocarditis virus; HHV-1, human" exact="herpes" post="virus type 1; VACV-WR, vaccinia virus strains Western Reserve;"/>
 <result pre="gamma coactivator 1-alpha, EMCv, encephalomyocarditis virus; HHV-1, human herpes virus" exact="type 1;" post="VACV-WR, vaccinia virus strains Western Reserve; SNS, Solanum nigrum"/>
 <result pre="EMCv, encephalomyocarditis virus; HHV-1, human herpes virus type 1; VACV-WR," exact="vaccinia" post="virus strains Western Reserve; SNS, Solanum nigrum seeds; TA,"/>
 <result pre="vaccinia virus strains Western Reserve; SNS, Solanum nigrum seeds; TA," exact="total" post="anthocyanins content; RV, rabies virus, HPLC-DAD, High-performance liquid chromatography-diode"/>
 <result pre="Reserve; SNS, Solanum nigrum seeds; TA, total anthocyanins content; RV," exact="rabies" post="virus, HPLC-DAD, High-performance liquid chromatography-diode array detector, CV-B1, coxsackievirus"/>
 <result pre="High-performance liquid chromatography-diode array detector, CV-B1, coxsackievirus B1; PV-1 poliovirus" exact="type 1;" post="HRSV-A2, human respiratory syncytial virus A2; FCV-F9, feline calicivirus-F9;"/>
 <result pre="detector, CV-B1, coxsackievirus B1; PV-1 poliovirus type 1; HRSV-A2, human" exact="respiratory" post="syncytial virus A2; FCV-F9, feline calicivirus-F9; MNV-1, murine norovirus-1;"/>
 <result pre="alba juice; MAS, Morus alba seed; Ad36, adenovirus 36; MCP-1," exact="monocyte" post="chemoattractant protein‐1; CJ, cranberry juice; BT2, bacteriophage T2; BT4,"/>
 <result pre="berry extract formula. Biochemistry (Mosc.)69 (1), 75–80. 10.1023/B:BIRY.0000016355.19999.9314972022 BeckerK.HuY.Biller-AndornoN. (2006)." exact="Infectious" post="diseases–a global challenge. Int. J. Med. Microbiol.296 (4–5), 179–185."/>
 <result pre="structure of anthocyanins. New York: Academic Press. 10.1016/B978-0-12-472550-8.50005-6 CallandN.DubuissonJ.RouilléY.SéronK. (2012)." exact="Hepatitis" post="C virus and natural compounds: a new antiviral approach?"/>
 <result pre="Viruses4 (10), 2197–2217. 10.3390/v410219723202460 CallandN.SahucM.-E.BelouzardS.PèneV.BonnafousP.MesalamA. A.et al. (2015). Polyphenols inhibit" exact="hepatitis" post="C virus entry by a new mechanism of action."/>
 <result pre="ChangL.-Y.TsaoK.-C.HsiaS.-H.ShihS.-R.HuangC.-G.ChanW.-K.et al. (2004). Transmission and clinical features of enterovirus 71" exact="infections" post="in household contacts in Taiwan. JAMA291 (2), 222–227. 10.1001/jama.291.2.22214722149"/>
 <result pre="household contacts in Taiwan. JAMA291 (2), 222–227. 10.1001/jama.291.2.22214722149 ChapondaM.PirmohamedM. (2011)." exact="Hypersensitivity" post="reactions to HIV therapy. Br. J. Clin. Pharmacol.71 (5),"/>
 <result pre="10.3390/nu11051052 ChenW.DimitrovD. S. (2012). Monoclonal antibody-based candidate therapeutics against HIV" exact="type 1." post="AIDS Res. Hum. Retroviruses28 (5), 425–434. 10.1089/aid.2011.022621827278 ChengH.-Y.YangC.-M.LinT.-C.LinL.-T.ChiangL.-C.LinC.-C. (2011)."/>
 <result pre="10.1089/aid.2011.022621827278 ChengH.-Y.YangC.-M.LinT.-C.LinL.-T.ChiangL.-C.LinC.-C. (2011). Excoecarianin, isolated from Phyllanthus urinaria Linnea, inhibits" exact="herpes" post="simplex virus type 2 infection through inactivation of viral"/>
 <result pre="Excoecarianin, isolated from Phyllanthus urinaria Linnea, inhibits herpes simplex virus" exact="type 2" post="infection through inactivation of viral particles. Evid. Based Complement."/>
 <result pre="from Phyllanthus urinaria Linnea, inhibits herpes simplex virus type 2" exact="infection" post="through inactivation of viral particles. Evid. Based Complement. Alternat."/>
 <result pre="inhibits herpes simplex virus type 2 infection through inactivation of" exact="viral" post="particles. Evid. Based Complement. Alternat. Med., 2011. 10.1093/ecam/nep157 ChonoK.KatsumataK.KontaniT.KobayashiM.SudoK.YokotaT.et"/>
 <result pre="novel helicase–primase inhibitor, possesses antiviral activity against varicella–zoster virus and" exact="herpes" post="simplex virus types 1 and 2. J. Antimicrob. Chemother.65"/>
 <result pre="possesses antiviral activity against varicella–zoster virus and herpes simplex virus" exact="types 1 and 2." post="J. Antimicrob. Chemother.65 (8), 1733–1741. 10.1093/jac/dkq19820534624 CisowskaA.WojniczD.HendrichA. B. (2011)."/>
 <result pre="ColmanP. M. (1994). Influenza virus neuraminidase: structure, antibodies, and inhibitors." exact="Protein" post="Sci.3 (10), 1687–1696. 10.1002/pro.55600310077849585 ColomboF.Di LorenzoC.RegazzoniL.FumagalliM.SangiovanniE.Peres de SousaL.et al."/>
 <result pre="J.WangC.DaiJ.MumperR. J.MillerC. S. (2011). Antiviral effects of blackberry extract against" exact="herpes" post="simplex virus type 1. Oral Surg. Oral Med. Oral"/>
 <result pre="(2011). Antiviral effects of blackberry extract against herpes simplex virus" exact="type 1." post="Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol.112"/>
 <result pre="Virol.19 (5), 287–299. 10.1002/rmv.62419714702 De ClercqE. (2015). Current treatment of" exact="hepatitis" post="B virus infections. Rev. Med. Virol.25 (6), 354–365. 10.1002/rmv.184926205627"/>
 <result pre="(4), 409–415. 10.1007/s00217-004-0912-7 Di GiuseppeR.Di CastelnuovoA.CentrittoF.ZitoF.De CurtisA.CostanzoS.et al. (2008). Regular" exact="consumption" post="of dark chocolate is associated with low serum concentrations"/>
 <result pre="L. DR2 peel exhibits antioxidant properties and anti-herpes simplex virus" exact="type 1" post="activity in vitro. Molecules23 (8), 2066. 10.3390/molecules23082066 Diaz-MulaH. M.Tomas-BarberanF."/>
 <result pre="DorhoiA.DobreanV.ZăhanM.ViragP. (2006). Modulatory effects of several herbal extracts on avian" exact="peripheral" post="blood cell immune responses. Phytother. Res.20 (5), 352–358. 10.1002/ptr.185916619362"/>
 <result pre="of an antioxidant-rich juice (sea buckthorn) on risk factors for" exact="coronary heart disease" post="in humans. J. Nutr. Biochem.13 (6), 346–354. 10.1016/S0955-2863(02)00179-112088800 EhrhardtC.DudekS."/>
 <result pre="an antioxidant-rich juice (sea buckthorn) on risk factors for coronary" exact="heart" post="disease in humans. J. Nutr. Biochem.13 (6), 346–354. 10.1016/S0955-2863(02)00179-112088800"/>
 <result pre="antioxidant-rich juice (sea buckthorn) on risk factors for coronary heart" exact="disease" post="in humans. J. Nutr. Biochem.13 (6), 346–354. 10.1016/S0955-2863(02)00179-112088800 EhrhardtC.DudekS."/>
 <result pre="II randomised controlled trial. Lancet369 (9569), 1261–1269. 10.1016/S0140-6736(07)60597-217434401 GuanY.ChenH. (2005)." exact="Resistance" post="to anti-influenza agents. Lancet366 (9492), 1139–1140. 10.1016/S0140-6736(05)67340-016198748 GubarevaL. V.KaiserL.HaydenF."/>
 <result pre="827–835. 10.1016/S0140-6736(99)11433-810711940 HakimM. S.SpaanM.JanssenH. L.BoonstraA. (2014). Inhibitory receptor molecules in" exact="chronic hepatitis" post="B and C infections: novel targets for immunotherapy? Rev."/>
 <result pre="10.1016/S0140-6736(99)11433-810711940 HakimM. S.SpaanM.JanssenH. L.BoonstraA. (2014). Inhibitory receptor molecules in chronic" exact="hepatitis" post="B and C infections: novel targets for immunotherapy? Rev."/>
 <result pre="antiviral properties of isochlorogenic acid A from Laggera alata against" exact="hepatitis" post="B virus infection. J. Ethnopharmacol.144 (1), 190–194. 10.1016/j.jep.2012.09.00322982394 HarborneJ."/>
 <result pre="of isochlorogenic acid A from Laggera alata against hepatitis B" exact="virus infection." post="J. Ethnopharmacol.144 (1), 190–194. 10.1016/j.jep.2012.09.00322982394 HarborneJ. B. (1967). Comparative"/>
 <result pre="(1967). Comparative biochemistry of the flavonoids-IV.: correlations between chemistry, pollen" exact="morphology" post="and systematics in the family plumbaginaceae. Phytochemistry6 (10), 1415–1428."/>
 <result pre="Org. Lett. (14), 7. 10.1021/ol300017m HuJ.RobinsonJ. L. (2010). Treatment of" exact="respiratory" post="syncytial virus with palivizumab: a systematic review. World J."/>
 <result pre="HusseinG.MiyashiroH.NakamuraN.HattoriM.KakiuchiN.ShimotohnoK. (2000). Inhibitory effects of Sudanese medicinal plant extracts on" exact="hepatitis" post="C virus (HCV) protease. Phytother. Res.14 (7), 510–516. 10.1002/1099-1573(200011)14:7&amp;lt;510::AID-PTR646&amp;gt;3.0.CO;2-B11054840"/>
 <result pre="Res.113 (3), 287–299. 10.1007/PL00013940 JackmanJ. A.LeeJ.ChoN. J. (2016). Nanomedicine for" exact="infectious disease" post="applications: innovation towards broad-spectrum treatment of viral infections. Small12"/>
 <result pre="(3), 287–299. 10.1007/PL00013940 JackmanJ. A.LeeJ.ChoN. J. (2016). Nanomedicine for infectious" exact="disease" post="applications: innovation towards broad-spectrum treatment of viral infections. Small12"/>
 <result pre="Nanomedicine for infectious disease applications: innovation towards broad-spectrum treatment of" exact="viral" post="infections. Small12 (9), 1133–1139. 10.1002/smll.20150085426551316 JacobJ. R.MansfieldK.YouJ. E.TennantB. C.KimY."/>
 <result pre="H. (2007). Natural iminosugar derivatives of 1-deoxynojirimycin inhibit glycosylation of" exact="hepatitis" post="viral envelope proteins. J. Microbiol.45 (5), 431–440. 17978803 JassimS."/>
 <result pre="(2007). Natural iminosugar derivatives of 1-deoxynojirimycin inhibit glycosylation of hepatitis" exact="viral" post="envelope proteins. J. Microbiol.45 (5), 431–440. 17978803 JassimS. A.NajiM."/>
 <result pre="JavedT.AshfaqU. A.RiazS.RehmanS.RiazuddinS. (2011). In-vitro antiviral activity of Solanum nigrum against" exact="Hepatitis" post="C Virus. Virol. J.8 (1), 26. 10.1186/1743-422X-8-2621247464 JayaprakasamB.VareedS. K.OlsonL."/>
 <result pre="M.KimJ. H.KimJ. Y.ParkJ.-Y.ParkS.-J.et al. (2012). Homoisoflavonoids from Caesalpinia sappan displaying" exact="viral" post="neuraminidases inhibition. Biol. Pharmaceut. Bull.35 (5), 786–790. 10.1248/bpb.35.786 JiangZ.-Y.LiuW.-F.ZhangX.-M.LuoJ.MaY.-B.ChenJ.-J."/>
 <result pre="of grape seed extract against feline calicivirus, murine norovirus, and" exact="hepatitis" post="A virus in model food systems and under gastric"/>
 <result pre="germination, one of which displays the antiviral activity against the" exact="rabies" post="virus infectivity and infections in culture. Microbiol. Immunol.51 (11),"/>
 <result pre="displays the antiviral activity against the rabies virus infectivity and" exact="infections" post="in culture. Microbiol. Immunol.51 (11), 1071–1079. 10.1111/j.1348-0421.2007.tb04002.x18037784 KayC. D.MazzaG.HolubB."/>
 <result pre="and serum. Br. J. Nutr.91 (6), 933–942. 10.1079/BJN2004112615228048 KepplerK.HumpfH.-U. (2005)." exact="Metabolism" post="of anthocyanins and their phenolic degradation products by the"/>
 <result pre="H.AtherA.ThompsonK. D.GambariR. (2005). Extracts and molecules from medicinal plants against" exact="herpes" post="simplex viruses. Antivir. Res.67 (2), 107–119. 10.1016/j.antiviral.2005.05.00216040137 KhanR.KhanA.AliA.IdreesM. (2019)."/>
 <result pre="production in vitro. Antivir. Res.37 (2), 131–140. 10.1016/S0166-3542(97)00069-79588845 KitazatoK.WangY.KobayashiN. (2007)." exact="Viral" post="infectious disease and natural products with antiviral activity. Drug"/>
 <result pre="in vitro. Antivir. Res.37 (2), 131–140. 10.1016/S0166-3542(97)00069-79588845 KitazatoK.WangY.KobayashiN. (2007). Viral" exact="infectious disease" post="and natural products with antiviral activity. Drug Discov. Ther.1"/>
 <result pre="vitro. Antivir. Res.37 (2), 131–140. 10.1016/S0166-3542(97)00069-79588845 KitazatoK.WangY.KobayashiN. (2007). Viral infectious" exact="disease" post="and natural products with antiviral activity. Drug Discov. Ther.1"/>
 <result pre="New helicase-primase inhibitors as drug candidates for the treatment of" exact="herpes" post="simplex disease. Nat. Med.8 (4), 392. 10.1038/nm0402-39211927946 KnoxY.HayashiK.SuzutaniT.OgasawaraM.YoshidaI.ShiinaR.et al."/>
 <result pre="10.1007/BF0206624824242734 KoumbiL. (2015). Current and future antiviral drug therapies of" exact="hepatitis" post="B chronic infection. World J. Hepatol.7 (8), 1030. 10.4254/wjh.v7.i8.103026052392"/>
 <result pre="(2015). Current and future antiviral drug therapies of hepatitis B" exact="chronic" post="infection. World J. Hepatol.7 (8), 1030. 10.4254/wjh.v7.i8.103026052392 KrawitzC.MraheilM. A.SteinM.ImirzaliogluC.DomannE.PleschkaS.et"/>
 <result pre="activity of a standardized elderberry liquid extract against clinically-relevant human" exact="respiratory" post="bacterial pathogens and influenza A and B viruses. BMC"/>
 <result pre="of a standardized elderberry liquid extract against clinically-relevant human respiratory" exact="bacterial" post="pathogens and influenza A and B viruses. BMC Complement."/>
 <result pre="LanariM.SilvestriM.RossiG. A. (2010). Palivizumab prophylaxis in ‘late preterm’newborns. J. Matern.Fetal" exact="Neonatal" post="Med.23 (sup3), 53–55. 10.3109/14767058.2010.50675720695756 LapidotT.HarelS.GranitR.KannerJ. (1998). Bioavailability of red"/>
 <result pre="4297–4302. 10.1021/jf980007o LarmoP.AlinJ.SalminenE.KallioH.TahvonenR. (2008). Effects of sea buckthorn berries on" exact="infections" post="and inflammation: a double-blind, randomized, placebo-controlled trial. Eur. J."/>
 <result pre="of mulberry (Morus alba) juice and its fractions on foodborne" exact="viral" post="surrogates. Foodborne Pathog. Dis.11 (3), 224–229. 10.1089/fpd.2013.163324350883 LeeJ.-H.BaeS. Y.OhM.SeokJ."/>
 <result pre="raspberry (Rubus coreanus) seed and its gallic acid against influenza" exact="virus infection." post="Viruses8 (6), 157. 10.3390/v8060157 LeeJ. S.KimH. J.LeeY. S. (2003)."/>
 <result pre="of antiviral drugs: a promising solution for the treatment of" exact="viral" post="infections. Expert Opin. Drug Deliv.15 (1), 93–114. 10.1080/17425247.2017.136086328749739 LiB."/>
 <result pre="LiB. Q.FuT.DongyanY.MikovitsJ. A.RuscettiF. W.WangJ. M. (2000). Flavonoid baicalin inhibits HIV-1" exact="infection" post="at the level of viral entry. Biochem. Biophys. Res."/>
 <result pre="(2000). Flavonoid baicalin inhibits HIV-1 infection at the level of" exact="viral" post="entry. Biochem. Biophys. Res. Commun.276 (2), 534–538. 10.1006/bbrc.2000.348511027509 LiS.-Y.YangD.YeungC.-M.YuW.-Y.ChangR."/>
 <result pre="534–538. 10.1006/bbrc.2000.348511027509 LiS.-Y.YangD.YeungC.-M.YuW.-Y.ChangR. C.-C.SoK.-F.et al. (2011). Lycium barbarum polysaccharides reduce" exact="neuronal" post="damage, blood-retinal barrier disruption and oxidative stress in retinal"/>
 <result pre="10.1155/S111072430440401X LimJ. K.MurphyP. M. (2011). Chemokine control of West Nile" exact="virus infection." post="Exp. Cell Res.317 (5), 569–574. 10.1016/j.yexcr.2011.01.00921376172 LinL.-T.ChenT.-Y.LinS.-C.ChungC.-Y.LinT.-C.WangG.-H.et al. (2013)."/>
 <result pre="Food Hydrocoll.73, 74–89. 10.1016/j.foodhyd.2017.06.036 LiuJ.ZhuM.ShiR.YangM. (2003). Radix Sophorae flavescentis for" exact="chronic hepatitis" post="B: a systematic review of randomized trials. Am. J."/>
 <result pre="Hydrocoll.73, 74–89. 10.1016/j.foodhyd.2017.06.036 LiuJ.ZhuM.ShiR.YangM. (2003). Radix Sophorae flavescentis for chronic" exact="hepatitis" post="B: a systematic review of randomized trials. Am. J."/>
 <result pre="H.CookeD.BrownK.StewardW. P.GescherA. J. (2009). Pharmacokinetics and metabolism of the putative" exact="cancer" post="chemopreventive agent cyanidin-3-glucoside in mice. Cancer Chemother Pharmacol.64 (6),"/>
 <result pre="metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice." exact="Cancer" post="Chemother Pharmacol.64 (6), 1261–1268. 10.1007/s00280-009-0996-719363608 MartinK.HeleniustA. (1991). Nuclear transport"/>
 <result pre="10.1007/s00280-009-0996-719363608 MartinK.HeleniustA. (1991). Nuclear transport of influenza virus ribonucleoproteins: the" exact="viral" post="matrix protein (M1) promotes export and inhibits import. Cell67"/>
 <result pre="S.WoodE.KerrT.LimaV.BarriosR.ShannonK.et al. (2010). Expanded highly active antiretroviral therapy coverage among" exact="HIV-positive" post="drug users to improve individual and public health outcomes."/>
 <result pre="Silymarin inhibits in vitro T-cell proliferation and cytokine production in" exact="hepatitis" post="C virus infection. Gastroenterology138 (2), 671–681. e672. 10.1053/j.gastro.2009.09.02119782083 NaH."/>
 <result pre="in vitro T-cell proliferation and cytokine production in hepatitis C" exact="virus infection." post="Gastroenterology138 (2), 671–681. e672. 10.1053/j.gastro.2009.09.02119782083 NaH. N.ParkS.JeonH. J.KimH. B.NamJ."/>
 <result pre="NaH. N.ParkS.JeonH. J.KimH. B.NamJ. H. (2014). Reduction of adenovirus 36-induced" exact="obesity" post="and inflammation by mulberry extract. Microbiol. Immunol.58 (5), 303–306."/>
 <result pre="entry coreceptors, CCR2b, CCR3 and CCR5 gene expression by normal" exact="peripheral" post="blood mononuclear cells. Biol. Res.35 (3–4), 421–431. 10.4067/S0716-9760200200030001612462994 NairN.MahajanS.ChawdaR.KandaswamiC.ShanahanT."/>
 <result pre="from species of the Lamiaceae family against Herpes simplex virus" exact="type 1" post="and type 2 in vitro. Planta Med.72 (15), 1378–1382."/>
 <result pre="the Lamiaceae family against Herpes simplex virus type 1 and" exact="type 2" post="in vitro. Planta Med.72 (15), 1378–1382. 10.1055/s-2006-95171917091431 NørbaekR.ChristensenL. P.BojesenG.BrandtK."/>
 <result pre="Antiviral effects of black raspberry (Rubus coreanus) juice on foodborne" exact="viral" post="surrogates. Foodborne Pathog. Dis.9 (10), 915–921. 10.1089/fpd.2012.117422924523 OparA. (2007)."/>
 <result pre="(3), 517–528. 10.1016/0092-8674(92)90452-I1374685 PojerE.MattiviF.JohnsonD.StockleyC. S. (2013). The case for anthocyanin" exact="consumption" post="to promote human health: a review. Compr. Rev. Food"/>
 <result pre="properties of a mangrove plant, Rhizophora apiculata Blume, against human" exact="immunodeficiency" post="virus. Antivir. Res.44 (2), 113–122. 10.1016/S0166-3542(99)00058-310669261 QinY.XiaM.MaJ.HaoY.LiuJ.MouH.et al. (2009)."/>
 <result pre="Ther.22 (8), 925–933. 10.1089/hum.2011.08721631241 RechtmanM. M.Har-NoyO.Bar-YishayI.FishmanS.AdamovichY.ShaulY.et al. (2010). Curcumin inhibits" exact="hepatitis" post="B virus via down-regulation of the metabolic coactivator PGC-1α."/>
 <result pre="C.Jr. (2007). Anthocyanin fraction from potato extracts is cytotoxic to" exact="prostate cancer" post="cells through activation of caspase-dependent and caspase-independent pathways. Carcinogenesis28"/>
 <result pre="(2007). Anthocyanin fraction from potato extracts is cytotoxic to prostate" exact="cancer" post="cells through activation of caspase-dependent and caspase-independent pathways. Carcinogenesis28"/>
 <result pre="lacto-wolfberry enhances the immune response and reduces pathogenesis to influenza" exact="infection" post="in mice. J. Nutr.142 (8), 1596–1602. 10.3945/jn.112.15946722739381 Revuelta-HerreroJ. L.Chamorro-de-VegaE.Rodríguez-GonzálezC."/>
 <result pre="1156–1164. 10.1017/S000711451000204720487584 SekizawaH.IkutaK.MizutaK.TakechiS.SuzutaniT. (2013). Relationship between polyphenol content and anti-influenza" exact="viral" post="effects of berries. J. Sci. Food Agric.93 (9), 2239–2241."/>
 <result pre="plants and tissue culture-derived materials against acyclovir-resistant Herpes simplex viruses" exact="type 1" post="(ACVr-HSV-1) and type 2 (ACVr-HSV-2). World J. Microbiol. Biotechnol.26"/>
 <result pre="materials against acyclovir-resistant Herpes simplex viruses type 1 (ACVr-HSV-1) and" exact="type 2" post="(ACVr-HSV-2). World J. Microbiol. Biotechnol.26 (1), 93. 10.1007/s11274-009-0147-7 SimõesC."/>
 <result pre="Lat. Am. J. Pharm.31 (1), 133–137. SimonV.HoD. D.KarimQ. A. (2006)." exact="HIV/AIDS" post="epidemiology, pathogenesis, prevention, and treatment. Lancet368 (9534), 489–504. 10.1016/S0140-6736(06)69157-516890836"/>
 <result pre="Dietary anthocyanins as a complementary medicinal approach for management of" exact="inflammatory bowel disease." post="Expert Rev. Gastroenterol. Hepatol.9 (6), 807–820. 10.1586/17474124.2015.100208625586636 SokmenM.AngelovaM.KrumovaE.PashovaS.IvanchevaS.SokmenA.et al."/>
 <result pre="anthocyanins as a complementary medicinal approach for management of inflammatory" exact="bowel" post="disease. Expert Rev. Gastroenterol. Hepatol.9 (6), 807–820. 10.1586/17474124.2015.100208625586636 SokmenM.AngelovaM.KrumovaE.PashovaS.IvanchevaS.SokmenA.et"/>
 <result pre="(1), 159–170. 10.1002/mnfr.20110052622102523 UhlP.FrickerG.HaberkornU.MierW. (2014). Current status in the therapy" exact="of liver" post="diseases. Int. J. Mol. Sci.15 (5), 7500–7512. 10.3390/ijms1505750024786290 UlbrichtC.BaschE.CheungL.GoldbergH.HammernessP.IsaacR.et"/>
 <result pre="UntenS.UshijimaH.ShimizuH.TsuchieH.KitamuraT.MoritomeN.et al. (1991). Effect of cacao husk extract on human" exact="immunodeficiency" post="virus infection. Lett. Appl. Microbiol.13 (6), 251–254. 10.1111/j.1472-765X.1991.tb00621.x1367748 ValadaresY."/>
 <result pre="al. (1991). Effect of cacao husk extract on human immunodeficiency" exact="virus infection." post="Lett. Appl. Microbiol.13 (6), 251–254. 10.1111/j.1472-765X.1991.tb00621.x1367748 ValadaresY. M.BrandãoG. C.KroonE."/>
 <result pre="Valiente-EcheverríaF.HermosoM. A.Soto-RifoR. (2015). RNA helicase DDX3: at the crossroad of" exact="viral" post="replication and antiviral immunity. Rev. Med. Virol.25 (5), 286–299."/>
 <result pre="Virol.25 (5), 286–299. 10.1002/rmv.184526174373 VassilakiN.FriebeP.MeulemanP.KallisS.KaulA.Paranhos-BaccalàG.et al. (2008). Role of the" exact="hepatitis" post="C virus core+ 1 open reading frame and core"/>
 <result pre="1 open reading frame and core cis-acting RNA elements in" exact="viral" post="RNA translation and replication. J. Virol.82 (23), 11503–11515. 10.1128/JVI.01640-0818799568"/>
 <result pre="(1978). Effect of treatment with certain flavonoids on Mengo virus-induced" exact="encephalitis" post="in mice. Arch. Virol.57 (3), 255–260. 10.1007/BF01315089209770 VishnuV. R.RenjithR."/>
 <result pre="2467–2475. 10.1021/acs.jafc.8b0547330741542 ViskelisP.RubinskienėM.JasutienėI.ŠarkinasA.DaubarasR.ČesonienėL. (2009). Anthocyanins, antioxidative, and antimicrobial properties of" exact="American" post="cranberry (Vaccinium macrocarpon Ait.) and their press cakes. J."/>
 <result pre="294–296. 10.1021/np980501m10075763 WangL.-S.StonerG. D. (2008). Anthocyanins and their role in" exact="cancer" post="prevention. Cancer Lett.269 (2), 281–290. 10.1016/j.canlet.2008.05.02018571839 WangX.JiaW.ZhaoA.WangX. (2006). Anti-influenza"/>
 <result pre="WangL.-S.StonerG. D. (2008). Anthocyanins and their role in cancer prevention." exact="Cancer" post="Lett.269 (2), 281–290. 10.1016/j.canlet.2008.05.02018571839 WangX.JiaW.ZhaoA.WangX. (2006). Anti-influenza agents from"/>
 <result pre="Antivir. Res.66 (1), 9–12. 10.1016/j.antiviral.2004.12.01115781126 WelliverR. C. (2010). Pharmacotherapy of" exact="respiratory" post="syncytial virus infection. Curr. Opin. Pharmacol.10 (3), 289–293. 10.1016/j.coph.2010.04.01320493773"/>
 <result pre="(1), 9–12. 10.1016/j.antiviral.2004.12.01115781126 WelliverR. C. (2010). Pharmacotherapy of respiratory syncytial" exact="virus infection." post="Curr. Opin. Pharmacol.10 (3), 289–293. 10.1016/j.coph.2010.04.01320493773 WilligJ. A. (2013)."/>
 <result pre="(2002). Absorption and metabolism of anthocyanins in elderly women after" exact="consumption" post="of elderberry or blueberry. J. Nutr.132 (7), 1865–1871. 10.1093/jn/132.7.186512097661"/>
 <result pre="with sea buckthorn (Hippophae rhamnoides) seed and pulp oils on" exact="atopic dermatitis." post="J. Nutr. Biochem.10 (11), 622–630. 10.1016/S0955-2863(99)00049-215539258 YangB.KallioH. (2002). Composition"/>
 <result pre="and 1, 3, 4, 6-tetra-O-galloyl-β-d-glucose isolated from Phyllanthus urinaria against" exact="herpes" post="simplex virus type 1 and type 2 infection. J."/>
 <result pre="4, 6-tetra-O-galloyl-β-d-glucose isolated from Phyllanthus urinaria against herpes simplex virus" exact="type 1" post="and type 2 infection. J. Ethnopharmacol.110 (3), 555–558. 10.1016/j.jep.2006.09.03917113739"/>
 <result pre="from Phyllanthus urinaria against herpes simplex virus type 1 and" exact="type 2" post="infection. J. Ethnopharmacol.110 (3), 555–558. 10.1016/j.jep.2006.09.03917113739 YangC. M.ChengH. Y.LinT."/>
 <result pre="acetone extract of Phyllanthus urinaria inhibited HSV-2 but not HSV-1" exact="infection" post="in vitro. Phytother. Res.21 (12), 1182–1186. 10.1002/ptr.223217661333 YangH.KimS.-K.KimM.RecheP. A.MoreheadT."/>
 <result pre="A.MoreheadT. J.DamonI. K.et al. (2005). Antiviral chemotherapy facilitates control of" exact="poxvirus infections" post="through inhibition of cellular signal transduction. J. Clin. Invest.115"/>
 <result pre="J.DamonI. K.et al. (2005). Antiviral chemotherapy facilitates control of poxvirus" exact="infections" post="through inhibition of cellular signal transduction. J. Clin. Invest.115"/>
 <result pre="inhibitors against NS3 helicase and NS5B RNA-dependent RNA polymerase from" exact="hepatitis" post="C virus 1b (Con1). Front. Microbiol.8, 2153. 10.3389/fmicb.2017.0215329209282 YeungA."/>
 <result pre="gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in" exact="respiratory" post="syncytial virus-infected immunocompromised mice. J. Virol.85 (24), 13061–13068. 10.1128/JVI.05869-1121937650"/>
</results>
